Table 1.
Medical problems | NF1 | PSC | PAH | MFS | Total N |
Aspects related to specific diagnoses | |||||
Tumours | 7 | 7 | |||
Problems of the respiratory system | 6 | 6 | |||
Thrombosis | 4 | 4 | |||
Epilepsy | 3 | 3 | |||
Aneurysms | 2 | 2 | |||
Coeliac disease | 2 | 2 | |||
Itching | 2 | 2 | |||
Cholestasis | 2 | 2 | |||
Incontinence | 2 | 2 | |||
Low body weight | 1 | 1 | |||
Restriction of renal function | 1 | 1 | |||
Endocarditis | 1 | 1 | |||
Iron deficiency | 1 | 1 | |||
Neurological disturbances of the sensitivity | 1 | 1 | |||
Brief reactive psychosis | 1 | 1 | |||
Shared aspects named by two diagnostic groups | |||||
Fatigue | 3 | 5 | 8 | ||
Hormonal abnormalities | 5 | 3 | 8 | ||
Disfigurement | 4 | 2 | 6 | ||
Neurological disturbances of the motor function | 4 | 1 | 5 | ||
Damages from surgery | 1 | 3 | 4 | ||
Skin problems | 1 | 2 | 3 | ||
Shared aspects named by three diagnostic groups | |||||
Diarrhoea | 1 | 9 | 1 | 11 | |
Limited eyesight | 2 | 1 | 5 | 8 | |
Pain | 1 | 1 | 3 | 5 | |
Side effects of medication | 1 | 1 | 1 | 3 |
Numbers represent the total number of mentions and are displayed for each diagnosis individually as well as across all diagnostic groups; grey cells represent categories, which were mentioned at least once in a diagnostic group.
MFS, Marfan syndrome; NF1, neurofibromatosis type 1; PAH, pulmonary arterial hypertension; PSC, primary sclerosing cholangitis.